Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Immune Landscape of Prostate Cancer and Nomination of PD-L2 as a Potential Therapeutic Target
Shuang G. Zhao, Jonathan Lehrer, S. Laura Chang, et al.
JNCI Journal of the National Cancer Institute (2018) Vol. 111, Iss. 3, pp. 301-310
Closed Access | Times Cited: 173

Showing 1-25 of 173 citing articles:

Tumor-Associated Macrophages in Human Breast, Colorectal, Lung, Ovarian and Prostate Cancers
Irina Larionova, Gulnara Tuguzbaeva, Anastasia A. Ponomaryova, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 314
CCL2-CCR2 axis recruits tumor associated macrophages to induce immune evasion through PD-1 signaling in esophageal carcinogenesis
Hui Yang, Qiannan Zhang, Miao Xu, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 313
The DNA methylation landscape of advanced prostate cancer
Shuang G. Zhao, William S. Chen, Haolong Li, et al.
Nature Genetics (2020) Vol. 52, Iss. 8, pp. 778-789
Open Access | Times Cited: 281
Immune and Inflammatory Cells in Thyroid Cancer Microenvironment
Silvia Martina Ferrari, Poupak Fallahi, Maria Rosaria Galdiero, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 18, pp. 4413-4413
Open Access | Times Cited: 190
The Tumor Immune Contexture of Prostate Cancer
Natasha Vitkin, Sarah Nersesian, D. Robert Siemens, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 184
Mast Cells, Angiogenesis and Lymphangiogenesis in Human Gastric Cancer
Giuseppe Sammarco, Gilda Varricchi, Valentina Ferraro, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 9, pp. 2106-2106
Open Access | Times Cited: 182
Revisiting Immunotherapy: A Focus on Prostate Cancer
Ha-Ram Cha, Joo Hyoung Lee, Selvarangan Ponnazhagan
Cancer Research (2020) Vol. 80, Iss. 8, pp. 1615-1623
Open Access | Times Cited: 173
How to turn up the heat on the cold immune microenvironment of metastatic prostate cancer
Jacob Stultz, Lawrence Fong
Prostate Cancer and Prostatic Diseases (2021) Vol. 24, Iss. 3, pp. 697-717
Open Access | Times Cited: 150
Dual Effect of Immune Cells within Tumour Microenvironment: Pro- and Anti-Tumour Effects and Their Triggers
Alicia Cristina Peña-Romero, Esteban Orenes‐Piñero
Cancers (2022) Vol. 14, Iss. 7, pp. 1681-1681
Open Access | Times Cited: 149
PD-1 and PD-L1: architects of immune symphony and immunotherapy breakthroughs in cancer treatment
Adil Parvez, Furqan Choudhary, Priyal Mudgal, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 71
Immune checkpoint inhibitors: breakthroughs in cancer treatment
Xueqing Kong, Jinyi Zhang, Shuwei Chen, et al.
Cancer Biology and Medicine (2024), pp. 1-11
Open Access | Times Cited: 24
Inflammation in cancer: therapeutic opportunities from new insights
Yifei Xie, Fangfang Liu, Yunfei Wu, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Mast Cells in the Tumor Microenvironment
Angélica Aponte-López, Samira Muñoz-Cruz
Advances in experimental medicine and biology (2020), pp. 159-173
Closed Access | Times Cited: 130
Cellular and Molecular Mechanisms Underlying Prostate Cancer Development: Therapeutic Implications
Ugo Testa, Germana Castelli, Elvira Pelosi
Medicines (2019) Vol. 6, Iss. 3, pp. 82-82
Open Access | Times Cited: 117
Recent Findings in the Regulation of Programmed Death Ligand 1 Expression
Xiangfeng Shen, Lihong Zhang, Ji‐Cheng Li, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 113
Transcriptomic Heterogeneity of Androgen Receptor Activity Defines a de novo low AR-Active Subclass in Treatment Naïve Primary Prostate Cancer
Daniel E. Spratt, Mohammed Alshalalfa, Nick Fishbane, et al.
Clinical Cancer Research (2019) Vol. 25, Iss. 22, pp. 6721-6730
Open Access | Times Cited: 96
Tumour immune cell infiltration and survival after platinum-based chemotherapy in high-grade serous ovarian cancer subtypes: A gene expression-based computational study
Rong Liu, Rong Hu, Ying Zeng, et al.
EBioMedicine (2020) Vol. 51, pp. 102602-102602
Open Access | Times Cited: 91
Resolving the immune landscape of human prostate at a single-cell level in health and cancer
Zewen Kelvin Tuong, Kevin W. Loudon, Brendan Berry, et al.
Cell Reports (2021) Vol. 37, Iss. 12, pp. 110132-110132
Open Access | Times Cited: 86
Comparative Genomics Reveals Distinct Immune-oncologic Pathways in African American Men with Prostate Cancer
Shivanshu Awasthi, Anders Berglund, Julieta Abraham-Miranda, et al.
Clinical Cancer Research (2020) Vol. 27, Iss. 1, pp. 320-329
Open Access | Times Cited: 79
LPAR1, Correlated With Immune Infiltrates, Is a Potential Prognostic Biomarker in Prostate Cancer
Jingqi Shi, Dongbo Jiang, Shuya Yang, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 78
Evolving landscape of PD-L2: bring new light to checkpoint immunotherapy
Yuqing Wang, Jiang Du, Zhenyue Gao, et al.
British Journal of Cancer (2022) Vol. 128, Iss. 7, pp. 1196-1207
Open Access | Times Cited: 66
Prostate cancer immunotherapy: a review of recent advancements with novel treatment methods and efficacy.
Ian Wang, Liankun Song, Beverly Y. Wang, et al.
PubMed (2022) Vol. 10, Iss. 4, pp. 210-233
Closed Access | Times Cited: 52
Comprehensive Analysis of m5C Methylation Regulatory Genes and Tumor Microenvironment in Prostate Cancer
Guopeng Yu, Jia-hao Bao, Ming Zhan, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 45
Sonodynamical reversion of immunosuppressive microenvironment in prostate cancer via engineered exosomes
Dingyi Wang, Zhuo Wan, Qian Yang, et al.
Drug Delivery (2022) Vol. 29, Iss. 1, pp. 702-713
Open Access | Times Cited: 43
Cancer-Associated Fibroblast: Role in Prostate Cancer Progression to Metastatic Disease and Therapeutic Resistance
Martina Bedeschi, Noemi Marino, Elena Cavassi, et al.
Cells (2023) Vol. 12, Iss. 5, pp. 802-802
Open Access | Times Cited: 32
Page 1 - Next Page

Scroll to top